» Articles » PMID: 21673186

A Systematic Comparison of Microsimulation Models of Colorectal Cancer: the Role of Assumptions About Adenoma Progression

Overview
Publisher Sage Publications
Date 2011 Jun 16
PMID 21673186
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As the complexity of microsimulation models increases, concerns about model transparency are heightened.

Methods: The authors conducted model "experiments" to explore the impact of variations in "deep" model parameters using 3 colorectal cancer (CRC) models. All natural history models were calibrated to match observed data on adenoma prevalence and cancer incidence but varied in their underlying specification of the adenocarcinoma process. The authors projected CRC incidence among individuals with an underlying adenoma or preclinical cancer v. those without any underlying condition and examined the impact of removing adenomas. They calculated the percentage of simulated CRC cases arising from adenomas that developed within 10 or 20 years prior to cancer diagnosis and estimated dwell time-defined as the time from the development of an adenoma to symptom-detected cancer in the absence of screening among individuals with a CRC diagnosis.

Results: The 20-year CRC incidence among 55-year-old individuals with an adenoma or preclinical cancer was 7 to 75 times greater than in the condition-free group. The removal of all adenomas among the subgroup with an underlying adenoma or cancer resulted in a reduction of 30% to 89% in cumulative incidence. Among CRCs diagnosed at age 65 years, the proportion arising from adenomas formed within 10 years ranged between 4% and 67%. The mean dwell time varied from 10.6 to 25.8 years.

Conclusions: Models that all match observed data on adenoma prevalence and cancer incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions. When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) "deep" model parameters and can provide guidance about specific areas in need of additional research and validation.

Citing Articles

MODELING EARLY-ONSET CANCER KINETICS TO STUDY CHANGES IN UNDERLYING RISK, DETECTION, AND IMPACT OF POPULATION SCREENING.

Mirzaei N, Hur C, Terry M, Dalerba P, Yang W medRxiv. 2024; .

PMID: 39677417 PMC: 11643252. DOI: 10.1101/2024.12.05.24318584.


Costs and benefits of a formal quality framework for colonoscopy: Economic evaluation.

Pakneshan S, Moy N, OConnor S, Hourigan L, Messmann H, Shah A Endosc Int Open. 2024; 12(11):E1334-E1341.

PMID: 39559417 PMC: 11573468. DOI: 10.1055/a-2444-6292.


Tailored recruitment interventions to improve bowel cancer screening in Arabic and Mandarin speaking groups: Modelled cost-effectiveness.

Lal A, Mohebi M, Wyatt K, Ghosh A, Broun K, Gao L PLoS One. 2024; 19(11):e0313058.

PMID: 39541269 PMC: 11563420. DOI: 10.1371/journal.pone.0313058.


Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.

Zaika V, Prakash M, Cheng C, Schlander M, Lang B, Beerenwinkel N PLoS One. 2024; 19(5):e0304374.

PMID: 38787836 PMC: 11125540. DOI: 10.1371/journal.pone.0304374.


Colorectal cancer screening: A review of current knowledge and progress in research.

Lopes S, Martins C, Santos I, Teixeira M, Gamito E, Alves A World J Gastrointest Oncol. 2024; 16(4):1119-1133.

PMID: 38660635 PMC: 11037045. DOI: 10.4251/wjgo.v16.i4.1119.


References
1.
van Ballegooijen M, Rutter C, Knudsen A, Zauber A, Savarino J, Lansdorp-Vogelaar I . Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making. 2011; 31(4):540-9. PMC: 3531980. DOI: 10.1177/0272989X11408915. View

2.
Ladabaum U, CHOPRA C, Huang G, Scheiman J, Chernew M, Fendrick A . Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med. 2001; 135(9):769-81. DOI: 10.7326/0003-4819-135-9-200111060-00007. View

3.
Rickert R, AUERBACH O, GARFINKEL L, HAMMOND E, FRASCA J . Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979; 43(5):1847-57. DOI: 10.1002/1097-0142(197905)43:5<1847::aid-cncr2820430538>3.0.co;2-l. View

4.
Mandel J, Church T, Ederer F, Bond J . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91(5):434-7. DOI: 10.1093/jnci/91.5.434. View

5.
Mandel J, Church T, Bond J, Ederer F, Geisser M, Mongin S . The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343(22):1603-7. DOI: 10.1056/NEJM200011303432203. View